Valuation: Neogen Corporation

Market Cap 2.62B 2.35B 2.19B 1.98B 3.74B 250B 3.76B 26.27B 10.28B 129B 9.84B 9.62B 416B P/E 2027 *
-78.3x
P/E 2028 * -109x
Enterprise Value 2.62B 2.35B 2.19B 1.98B 3.74B 250B 3.76B 26.27B 10.28B 129B 9.84B 9.62B 416B EV / Sales 2027 *
2.95x
EV / Sales 2028 * 3x
Free-Float
99.25%
Yield 2027 *
-
Yield 2028 * -

Last Transcript: Neogen Corporation

1 day+1.27%
1 week-7.76%
Current month-6.25%
1 month+1.87%
3 months+24.74%
6 months+27.39%
Current year+71.67%
1 week 11.13
Extreme 11.1337
12.92
1 month 11.13
Extreme 11.1337
14.26
Current year 6.89
Extreme 6.89
14.26
1 year 5.37
Extreme 5.37
14.26
3 years 3.87
Extreme 3.8701
20.89
5 years 3.87
Extreme 3.8701
47.8
10 years 3.87
Extreme 3.8701
48.85
Manager TitleAgeSince
Chief Executive Officer 50 10/08/2025
Director of Finance/CFO 56 02/11/2025
Compliance Officer 61 07/04/2026
Director TitleAgeSince
Director/Board Member 65 31/12/2013
Chairman 70 09/04/2020
Director/Board Member 58 07/10/2020
Date Insider Type Main position Quantity % Market Cap. Importance
09/10/26 Buy

Chief Executive Officer

505 0.0002%
01/10/26 Free

Director

30,362 0.0139%
01/10/26 Free

Director

30,362 0.0139%
Change 5-day change 1-year change 3-year change Capi.($)
+1.27%-7.76%+98.68%-19.84% 2.62B
+2.23%+1.72%-23.20%+12.89% 176B
+3.90%+4.50%-3.69%+28.95% 118B
+1.90%-0.92%-22.49%+11.33% 108B
-0.10%-0.07%-46.61%-10.66% 75.34B
+0.37%+3.22%+2.22%+73.30% 62.03B
+1.04%+0.06%+19.35%+61.96% 52.8B
+2.80%+4.55%+1.25%-26.52% 51.45B
+1.15%-0.59%-14.97%+22.33% 41.28B
-1.38%-0.11% - - 31.37B
Average +0.99%+1.66%+1.17%+17.08% 71.91B
Weighted average by Cap. +1.24%+2.14%-13.97%+19.52%

Financials

2027 *2028 *
Net sales 887M 794M 740M 671M 1.27B 84.75B 1.27B 8.89B 3.48B 43.74B 3.33B 3.26B 141B 875M 783M 730M 662M 1.25B 83.6B 1.26B 8.77B 3.43B 43.14B 3.29B 3.21B 139B
Net income -33.93M -30.38M -28.32M -25.69M -48.44M -3.24B -48.75M -340M -133M -1.67B -127M -125M -5.39B -23.73M -21.25M -19.81M -17.96M -33.88M -2.27B -34.1M -238M -93.17M -1.17B -89.15M -87.18M -3.77B
Net Debt - -
Projected Income Statement - Annual - Neogen Corporation
Logo Neogen Corporation
Neogen Corporation and subsidiaries are engaged in developing, manufacturing and marketing a diverse line of products and services dedicated to food and animal safety. The Company has developed comprehensive solutions spanning the Food Safety, Livestock, and Pet Health & Wellness markets. Its segments include Food Safety and Animal Safety. The Food Safety segment is primarily engaged in the development, production and marketing of diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens and levels of general sanitation. The Animal Safety segment is primarily engaged in the development, production and marketing of products dedicated to animal safety, including a complete line of consumable products marketed to veterinarians and animal health product distributors. This segment also provides genomic identification and related interpretive bioinformatic services.
Employees
2,636
Date Price Change Volume
12/10/26 US$12.00 +1.27% 2,570,500
09/10/26 US$11.85 +1.20% 3,647,744
08/10/26 US$11.71 +0.26% 8,670,443
07/10/26 US$11.68 -2.34% 12,969,335
06/10/26 US$11.96 -8.07% 5,970,883
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
A
MarketScreener Ratings - Neogen Corporation
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
12.00USD
Average target price
14.00USD
Spread / Average Target
+16.67%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Neogen Corporation
  1. Stock Market
  2. Stocks
  3. NEOG Stock